Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Idioma
Intervalo de año de publicación
1.
Tsitologiia ; 38(9): 934-48, 1996.
Artículo en Ruso | MEDLINE | ID: mdl-9019896

RESUMEN

The paper deals with a cytofluorimetric study of the content of glycogen and its fractions as well as with a microbiochemical study of glucose-6-phosphatase, glycogen phosphorylase, and glycogen synthase activities in the rat liver parenchyma cells in norm, in the course of cirrhosis development, and at various time intervals after the end of the carbon tetrachloride (CCl4) poisoning and after a partial hepatectomy (PH). Serial liver biopsies were obtained from each animal prior to CCl4 action (control), 6 months after a chronic intoxication with CCl4 inducing liver cirrhosis, and then 3 and 6 months after the end of CCl4 poisoning of rats, and after the cirrhotic liver PH. It has been shown that the total glycogen content in the cirrhotic liver hepatocytes increases by 1.4-1.5 times, compared with control, however, it returns to the norm 6 months after the PH. The glycogen labile fraction (LF), that accounts for 85% of the total glycogen, amounted to 65% in liver cirrhosis. The most striking changes in liver cirrhosis occurred in the glycogen stable fraction (SF) which rose by 3.9 times in the cirrhotic liver. The LF/SF ratio returned to the norm 6 months after the PH. The activity of glucose-6-phosphatase fell by 2.7 times in the liver cirrhosis; its activity after the PH initially increased, then decreased again to reach 6 months after the PH the same level as in the cirrhotic liver before the PH. The activities of glycogen phosphorylase and glycogen synthase returned to the normal level 6 months after the PH. The results of the current study make it possible to conclude that the PH of the cirrhotic liver facilitates only a partial restoration of the glycogen forming function of hepatocytes.


Asunto(s)
Hepatectomía/métodos , Cirrosis Hepática Experimental/enzimología , Glucógeno Hepático/biosíntesis , Regeneración Hepática/fisiología , Hígado/enzimología , Animales , Biopsia con Aguja , Intoxicación por Tetracloruro de Carbono/complicaciones , Intoxicación por Tetracloruro de Carbono/enzimología , Intoxicación por Tetracloruro de Carbono/patología , Hígado/química , Hígado/patología , Cirrosis Hepática Experimental/inducido químicamente , Cirrosis Hepática Experimental/patología , Glucógeno Hepático/análisis , Masculino , Ratas , Factores de Tiempo
2.
Klin Med (Mosk) ; 74(8): 55-8, 1996.
Artículo en Ruso | MEDLINE | ID: mdl-9036213

RESUMEN

The effect of magnesium sulfate aerosol (osmolality of the solution 260 mmol/l, pH 6.6) on bronchial sensitivity and reactivity to acetylcholine (AC) and graded exercise as well as bronchial permeability measured by general plethysmography and pneumotaxography were evaluated in 49 patients with mild and moderate bronchial asthma (BA). When compared to placebo, magnesium sulfate (MS) inhalations performed at the stage of attenuating exacerbation, improved immediate and long-term response of patients with atopic and effort BA. In this disease, both single and course doses of MS reduced nonspecific bronchial hyperreactivity and secretory activity of mast cells. A positive trend in the parameters of AC provocative test predicted efficacy of MS treatment in the majority of BA sufferers.


Asunto(s)
Antiasmáticos/uso terapéutico , Asma/tratamiento farmacológico , Broncoconstricción/efectos de los fármacos , Sulfato de Magnesio/uso terapéutico , Administración por Inhalación , Adolescente , Adulto , Aerosoles/administración & dosificación , Antiasmáticos/administración & dosificación , Asma/metabolismo , Asma/fisiopatología , Bronquios/efectos de los fármacos , Bronquios/metabolismo , Bronquios/fisiopatología , Broncodilatadores/administración & dosificación , Sinergismo Farmacológico , Quimioterapia Combinada , Femenino , Fenoterol/administración & dosificación , Estudios de Seguimiento , Humanos , Sulfato de Magnesio/administración & dosificación , Masculino , Persona de Mediana Edad , Permeabilidad/efectos de los fármacos , Pletismografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA